Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing Cui

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibodySuping Zhang, Han Zhang, Emanuela M Ghia, et al.
Cancer Letters|January 14, 2020
Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signalingJiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Cancer Letters|January 1, 2025
Corrigendum to "Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling" [Cancer Lett. 474 (2020) 23-35]Jiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Immunity|October 13, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Nature Communications|July 23, 2020
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic targetJiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, et al.
Nature Communications|December 10, 2020
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradationKe Li, Feng Wang, Zhao-Na Yang, et al.
Nature Communications|January 3, 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemiaFeng Wang, Yunxuan Li, Zhaona Yang, et al.
Autophagy|July 10, 2019
Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activationXiao-Wei Zhang, Ji-Chao Zhou, Dian Peng, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibodySuping Zhang, Han Zhang, Emanuela M Ghia, et al.
Cancer Letters|January 14, 2020
Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signalingJiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Cancer Letters|January 1, 2025
Corrigendum to "Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling" [Cancer Lett. 474 (2020) 23-35]Jiao-Jiao Yu, Dan-Dan Zhou, Bing Cui, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Immunity|October 13, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Nature Communications|July 23, 2020
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic targetJiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, et al.
Nature Communications|December 10, 2020
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradationKe Li, Feng Wang, Zhao-Na Yang, et al.
Nature Communications|January 3, 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemiaFeng Wang, Yunxuan Li, Zhaona Yang, et al.
Autophagy|July 10, 2019
Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activationXiao-Wei Zhang, Ji-Chao Zhou, Dian Peng, et al.
Pageof 29